Lowe Wealth Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Lowe Wealth Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-25	Closed	-$5K	–	295
2021 Q1	$5K	Hold	25	–	–	﹤0.01%	212
2020 Q4	$3K	Hold	25	–	–	﹤0.01%	232
2020 Q3	$2K	Hold	25	–	–	﹤0.01%	236
2020 Q2	$3K	Hold	25	–	–	﹤0.01%	220
2020 Q1	$2K	Hold	25	–	–	﹤0.01%	252
2019 Q4	$3K	Hold	25	–	–	﹤0.01%	233
2019 Q3	$3K	Hold	25	–	–	﹤0.01%	225
2019 Q2	$4K	Hold	25	–	–	﹤0.01%	221
2019 Q1	$4K	Hold	25	–	–	﹤0.01%	194
2018 Q4	$2K	Hold	25	–	–	﹤0.01%	224
2018 Q3	$4K	Hold	25	–	–	﹤0.01%	222
2018 Q2	$3K	Buy	+25	New	+$3.55K	﹤0.01%	194

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Lowe Wealth Advisors's GWPH Position: Q2 2021 in Review

Lowe Wealth Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 25 shares — an estimated $5K sold.

Lowe Wealth Advisors first reported a position in GWPH in Q2 2018 and held it in 12 quarters. The position peaked at $5K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Lowe Wealth Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Lowe Wealth Advisors sold 25 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $5K.
Lowe Wealth Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 12 quarters.
Lowe Wealth Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $5K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Lowe Wealth Advisors's 13F filing for Q2 2021, filed 1 Jul 2021.